BACKGROUND: There is difficulty in gathering data on the prevalence of human T-cell lymphotropic virus in blood donors as confirmatory testing is not mandatory in Brazil. This suggests there may be an underreporting of the prevalence. OBJECTIVE: To estimate the prevalence of human T-cell lymphotropic virus types 1 and 2 in donors of a blood bank in Caruaru, Brazil. METHODS: This was an observational, epidemiological, descriptive, longitudinal and retrospective study with information about the serology of donors of the Caruaru Blood Center, Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope) from May 2006 to December 2010. The data were analyzed using the Excel 2010 computer program (Microsoft Office(®)). RESULTS: Of 61,881 donors, 60 (0.096%) individuals were identified as potential carriers of human T-cell lymphotropic virus types 1 and 2. Of these, 28 (0.045%) were positive and 32 (0.051%) had inconclusive results in the serological screening. Forty-five (0.072%) were retested; 17 were positive (0.027%) and 3 inconclusive (0.005%). After confirmatory tests, 8 were positive (0.013%). Six (75%) of the confirmed cases were women. CONCLUSION: Epidemiological surveys like this are very important in order to create campaigns to attract donors and reduce the costs of laboratory tests.
BACKGROUND: There is difficulty in gathering data on the prevalence of human T-cell lymphotropic virus in blood donors as confirmatory testing is not mandatory in Brazil. This suggests there may be an underreporting of the prevalence. OBJECTIVE: To estimate the prevalence of human T-cell lymphotropic virus types 1 and 2 in donors of a blood bank in Caruaru, Brazil. METHODS: This was an observational, epidemiological, descriptive, longitudinal and retrospective study with information about the serology of donors of the Caruaru Blood Center, Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope) from May 2006 to December 2010. The data were analyzed using the Excel 2010 computer program (Microsoft Office(®)). RESULTS: Of 61,881 donors, 60 (0.096%) individuals were identified as potential carriers of human T-cell lymphotropic virus types 1 and 2. Of these, 28 (0.045%) were positive and 32 (0.051%) had inconclusive results in the serological screening. Forty-five (0.072%) were retested; 17 were positive (0.027%) and 3 inconclusive (0.005%). After confirmatory tests, 8 were positive (0.013%). Six (75%) of the confirmed cases were women. CONCLUSION: Epidemiological surveys like this are very important in order to create campaigns to attract donors and reduce the costs of laboratory tests.
Entities:
Keywords:
Blood banks; Blood donors/statistics & numerical data; Epidemiology; Health promotion; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2
Authors: Carolina A Berini; Silvina A Gendler; Susana Pascuccio; Maria E Eirin; Willi McFarland; Kimberly Page; Luisa Carnevali; Edward Murphy; Mirna M Biglione Journal: J Med Virol Date: 2010-05 Impact factor: 2.327
Authors: Bernadette Catalan-Soares; Anna Bárbara de F Carneiro-Proietti; Fernando Augusto Proietti Journal: Cad Saude Publica Date: 2005-05-02 Impact factor: 1.632
Authors: A Manns; R J Wilks; E L Murphy; G Haynes; J P Figueroa; M Barnett; B Hanchard; W A Blattner Journal: Int J Cancer Date: 1992-07-30 Impact factor: 7.396
Authors: Nanci A Salles; Ester C Sabino; Claudia C Barreto; Angela M E Barreto; Marcia M Otani; Dalton F Chamone Journal: Rev Panam Salud Publica Date: 2003 Feb-Mar
Authors: J E Kaplan; R F Khabbaz; E L Murphy; S Hermansen; C Roberts; R Lal; W Heneine; D Wright; L Matijas; R Thomson; D Rudolph; W M Switzer; S Kleinman; M Busch; G B Schreiber Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-06-01
Authors: Maria P S Orletti; Tatiane Assone; Glenia Daros Sarnaglia; Marina Lobato Martins; Carolina Rosadas; Jorge Casseb; Graham Taylor; Joaquim B Ferreira-Filho; Fausto E L Pereira; Angélica Espinosa Miranda Journal: Braz J Infect Dis Date: 2021-10-14 Impact factor: 3.257